Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Bijin Thajudeen
Associate Professor, Medicine - (Clinical Scholar Track)
Medicine
Overview
Research
More
Collaboration
(17)
Tirdad Zangeneh
Mutual work: 1 Publication
Collaboration Details
Robert Harland
Mutual work: 1 Publication
Collaboration Details
Jarrod Mosier
Mutual work: 1 Publication
Collaboration Details
Daniel Combs
Mutual work: 1 Publication
Collaboration Details
Kurt Denninghoff
Mutual work: 1 Grant
Collaboration Details
Page 1 of 4
Previous page
Next page
Grants
(15)
A Phase 3 Randomized Controlled Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 2 Diabetes and Chronic Kidney Disease (REGEN-006)
Active
·
2023
·
$3.9M / $770.6K
·
External
Principal Investigator (PI)
cell therapy,
diabetes,
chronic kidney disease,
clinical trial,
renal therapy
Geographic and Environmental Health Equity in Kidney Precision Medicine
Active
·
2022
·
$21.7K / $361.2K
·
External
Co-Investigator (COI)
geographic health,
environmental health,
kidney precision medicine,
health equity,
precision medicine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants Who Have Thrombotic Microangiopathy Associated With
Active
·
2021
·
$217.7K
·
External
Principal Investigator (PI)
pharmacology,
clinical trials,
hematology,
immunology,
biotechnology
Assessing Outcomes of Patients with Primary FSGS A Multicenter Real-World Observational Study
Active
·
2021
·
$0 / $25.2K
·
External
Co-Investigator (COI)
kidney disease,
clinical outcomes,
multicenter,
fsgs
A Phase 2, Prospective, Randomized, Double-Arm, Deferred Treatment, Open-Label, Repeat Dose, Safety and Efficacy Study of Autologous Neo-Kidney Augment (NKA) in Subjects with Type 2 Diabetes
Active
·
2017
·
$475K
·
External
Principal Investigator (PI)
diabetes,
clinical trial,
regenerative medicine,
nephrology,
medical treatment
Page 1 of 3
Previous page
Next page
Publications
(35)
Recent
Renal Autologous Cell Therapy in Type 2 Diabetes with Late Stage 4 Diabetes-Related Chronic Kidney Disease: Trial Design and Early Analysis
2023
Effectiveness of casirivimab-imdevimab and sotrovimab monoclonal antibody treatment among high-risk patients with sars-cov-2 infection: a real-world experience
2023
Advances in hemodialysis therapy
2023
Contemporary Monoclonal Antibody Utilization in Glomerular Diseases
2023
monoclonal antibodies,
glomerular diseases,
contemporary medicine,
immunotherapy,
nephrology
Precision Medicine in Nephrology: An Integrative Framework of Multidimensional Data in the Kidney Precision Medicine Project
2023
precision medicine,
nephrology,
integrative framework,
multi-dimensional data,
kidney
The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era
2023
covid-19,
antiviral,
hospitalizations,
high-risk patients,
omicron variant
Renal Considerations in COVID-19: Biology, Pathology, and Pathophysiology
2021
renal considerations,
covid-19,
biology,
pathology,
pathophysiology
Chronic kidney disease unawareness and determinants using 1999-2014 National Health and Nutrition Examination Survey Data
2021
chronic kidney disease,
awareness,
determinants,
health survey,
nutrition
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD
2021
Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria
2021
covid-19,
kidney biopsies,
acute kidney injury,
proteinuria,
clinicopathologic correlation